About the Company
QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located respectively in Hilden, Germany; Germantown, Maryland, United States; Shanghai, China; and Singapore. QIAGEN's shares are listed at the NYSE (using ticker QGEN) and at the Frankfurt Stock Exchange in the Prime Standard (using ticker QIA). Thierry Bernard is the company's Chief Executive Officer (CEO).
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on QIAGEN N.V.
QIAGEN N.V. Announces Managerial Share Sale by Roland Sackers
Qiagen ( ($QGEN) ) has shared an announcement. QIAGEN N.V. announced a managerial transaction involving Mr. Roland Sackers, a member of the ...
What to Expect from Qiagen NV (QGEN) Q2 2025 Earnings
Qiagen NV (NYSE:QGEN) is set to release its Q2 2025 earnings on Aug 6, 2025. The consensus estimate for Q2 2025 revenue is ...
Qiagen N.V. (NYSE:QGEN) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Call Transcript August 6, 2025 Operator: Ladies and gentlemen, thank you for standing by. I am Katie, your ...
Qiagen NV ( NYSE:QGEN ) Estimates Trends - Yahoo Finance
Qiagen NV (NYSE:QGEN) is set to release its Q3 2024 earnings on Nov 7, 2024. The consensus estimate for Q3 2024 revenue is $491.75 million, and the earnings are expected to come in at $0.62 per ...
QIAGEN N.V. to Release Results for Q1 2025 and Hold Webcast
QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the first quarter 2025. Press release date / time: Wednesday, May 7, shortly after 22:05 Frankfurt ...
1QGEN | Qiagen N.V. Stock Overview (Italy: Milan) | Barron's
Complete Qiagen N.V. stock information by Barron's. View real-time 1QGEN stock price and news, along with industry-best analysis.
Qiagen N.V. Research & Ratings | 1QGEN | Barron's
Qiagen N.V. research and ratings by Barron's. View 1QGEN revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.
Here’s What Hedge Funds Think About Qiagen NV (QGEN)
Qiagen NV (NYSE: QGEN) investors should be aware of an increase in enthusiasm from smart money lately. Our calculations also showed that qgen isn’t among the 30 most popular stocks among hedge ...
Qiagen shares surge as diagnostics group says open to takeover talks ...
Qiagen NV shares jumped to their highest in almost 19 years on Monday after the German genetic testing company said it would start talks with several potential suitors. FRANKFURT, Nov 18 (Reuters ...
Qiagen agrees to buy Artus GmbH for $39 million - MarketWatch
LONDON (MarketWatch) -- Biotech firm Qiagen NV said it has agreed to buy molecular diagnostic tests maker Artus GmbH for $39.2 million in cash, with $11.6 million of this subject to certain ...
Similar Companies
Loading the latest forecasts...